GROWTH STOCK ANALYZER Open the app
Growth Stock Analyzer › HSIC growth analysis
Growth stock analysis · updated 2026-07-27

Henry Schein Inc (HSIC) growth stock analysis

Is Henry Schein Inc a growth stock? A data-driven read on its earnings momentum, price leadership, and demand, scored against every US stock from SEC filings and daily prices, and re-ranked after every close.

Not right now by CANSLIM
29
Growth score
68
RS rating
#2,035
Rank
1/6
Traits passed
29/99
Growth score · 2035th of 4,897 US stocks
CANSLI
Six growth traits, scored 1–99

What the data says about HSIC

As of the 2026-07-27 close, HSIC scores 29 out of 99 on our growth-stock rating, a weak growth-stock profile. That ranks it 2035th of 4,897 rated US stocks, the top 42% of the market.

Its strongest trait is N (new highs & catalysts) at 63, and its weakest is A (annual earnings growth) at 28. HSIC clears 1 of the six core growth traits we score per stock; the seventh, overall market direction, is judged market-wide.

On price, HSIC carries a middling Relative Strength rating of 68, meaning it has outperformed about 68% of the market over the past year.

Underneath the score: quarterly earnings up 5% year over year, sales up 6%, trading 5% below its 52-week high.

HSIC growth-trait breakdown

The six traits that separate real growth stocks from the rest: earnings, price leadership, and demand. Each is scored 1–99 against the whole US market. We compute them with the CANSLIM method, double-weighting earnings and relative strength.

C
Current quarterly earnings
most recent EPS growth vs. a year ago
55
A
Annual earnings growth
multi-year earnings trend
28
N
New highs & catalysts
proximity to new 52-week highs
63
S
Supply & demand
volume behind the move vs. share supply
41
L
Leader or laggard
Relative Strength within its group
53
I
Institutional sponsorship
fund accumulation and 13F ownership
56

Is HSIC a growth stock?

Not right now by CANSLIM

On today’s data HSIC does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

🔒 Stronger growth stocks than HSIC

The stocks ranking above HSIC today, the growth leaders you’d weigh against it.

See today’s top ranks for free →

🔒 HSIC price history & buy range

Where HSIC sits in its base, its 52-week path, and the trait trend over the past year.

Open the full HSIC profile →

See where HSIC ranks among every US growth stock

Every US stock scored on the traits that define a growth stock and re-ranked after each close, with the top ranks, the full trait breakdown, and today’s market read.

Open the app, free through September 1

HSIC as a growth stock, frequently asked

Is HSIC a good growth stock?

Not right now by CANSLIM. On today’s data HSIC does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

What is HSIC's growth score?

Henry Schein Inc (HSIC) scores 29 out of 99 on our growth-stock rating as of the 2026-07-27 close, ranking 2035th of 4,897 rated US stocks.

Does HSIC have strong earnings growth?

HSIC's most recent quarterly earnings were up about 5% year over year, with sales up 6%.

How strong is HSIC's price performance?

HSIC has a Relative Strength rating of 68, meaning it has outperformed roughly 68% of the US market over the trailing year.

Where can I see HSIC's full analysis?

Create a free Growth Stock Analyzer account to see where HSIC ranks against every US stock, the stronger growth stocks to weigh against it, and its full price and earnings history.

Want the method behind the score? Read how we grade growth stocks with CANSLIM.

More growth stocks in Wholesale-Medical, Dental & Hospital Equipment & Supplies